Market Cap (In KRW)
2537.44 Billion
Revenue (In KRW)
388.79 Billion
Net Income (In KRW)
21.26 Billion
Avg. Volume
223.1 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 49600.0-133300.0
- PE
- -
- EPS
- -
- Beta Value
- 0.251
- ISIN
- KR7068760008
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jung-su Seo
- Employee Count
- -
- Website
- https://www.celltrionph.com
- Ipo Date
- 2006-02-03
- Details
- Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju, South Korea.
More Stocks
-
B52
-
603196Ribo Fashion Group Co., Ltd.
603196
-
RRR
-
NTG
-
VSL
-
FMCCI
-
FLXI
-
PPG